Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
News

AI opens new frontier for suicide prevention

Lauren Vogel
CMAJ January 29, 2018 190 (4) E119; DOI: https://doi.org/10.1503/cmaj.109-5549
Lauren Vogel
CMAJ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

In the early hours of the morning, a distraught teen posts on social media about wanting to hurt herself. Her friends and family are sleeping, but an algorithm answers, providing links to 24/7 help.

Artificial intelligence already sorts what you see on social media, but increasingly, it’s being harnessed to monitor and respond to mental health crises.

Canada is at the cutting edge of the development. The federal government recently tapped an Ottawa-based AI company to screen social media posts for warning signs of suicide. According to a contract, Advanced Symbolics will work with the government to define “suicide-related behavior” — from thoughts to threats to attempts — and conduct market research to identify related patterns of online behavior. For example, do people who self-harm tweet about it?

Based on the findings, the company will conduct a three-month pilot monitoring online discussions about suicide, after which the Public Health Agency of Canada “will determine if future work would be useful for ongoing suicide surveillance.”

The project will use public data and won’t identify individuals. According to Advanced Symbolics chief scientist Kenton White, the goal is to identify “hot spots” of suicide risk so the government can provide resources to communities before tragedy strikes. The company previously used the same technology to forecast the outcomes of elections in Canada, the United States and Europe, accurately predicting the breakdown of the popular vote in the 2016 US presidential election within 0.7 percentage points.

In November, Facebook rolled out an AI program that scans posts and live videos for threats of suicide and self-harm, and alerts a team of human reviewers, who can contact emergency responders if needed. “In the last month alone, these AI tools have helped us connect with first responders quickly more than 100 times,” Facebook founder Mark Zuckerberg announced on the site. The company also reported that its AI has been able to identify and remove 99% of posts related to the terrorist groups ISIS and Al Qaeda before users flagged the content, “and in some cases, before it goes live on the site.”

Figure

Canada is joining a vanguard of countries and companies using artificial intelligence and social media to assess mental health risk.

Image courtesy of peepo/iStock

Other companies are using social media monitoring to explore the link between online conversations and mental health. A recent Brandwatch study of 12.9 million posts from July 2014 to June 2017 found that people in the United Kingdom who shared about symptoms of mental disorders and being bullied were more than six times more likely to reference self-harm in posts. The study also found that only 23% of people in the UK who repeatedly posted about “mental health risk symptoms,” such as sleep disruption, anxiety and appetite changes, later referenced seeking help, compared to 33% in the US. For those who didn’t describe receiving treatment, posts about their symptoms escalated in both frequency and negativity.

Footnotes

  • Posted on cmajnews.com on Jan. 8, 2018.

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 190 (4)
CMAJ
Vol. 190, Issue 4
29 Jan 2018
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
AI opens new frontier for suicide prevention
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
AI opens new frontier for suicide prevention
Lauren Vogel
CMAJ Jan 2018, 190 (4) E119; DOI: 10.1503/cmaj.109-5549

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
AI opens new frontier for suicide prevention
Lauren Vogel
CMAJ Jan 2018, 190 (4) E119; DOI: 10.1503/cmaj.109-5549
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • AI-enabled suicide prediction tools: ethical considerations for medical leaders
  • AI enabled suicide prediction tools: a qualitative narrative review
  • Google Scholar

More in this TOC Section

  • Resignations at Canada’s drug pricing panel raise independence questions
  • Provinces accept federal health funding deal
  • Feds propose $196B health funding deal with few strings attached
Show more News

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire